Prudential Financial’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.3K Buy
12,270
+880
+8% +$6.95K ﹤0.01% 2344
2026
Q1
$77.3K Buy
+11,390
New +$84.2K ﹤0.01% 2260

Other funds holding CRMD

Prudential Financial's CRMD Position: Q2 2026 in Review

Prudential Financial increased its CorMedix (CRMD) stake by 7.7% in Q2 2026, buying an estimated $6.95K and bringing the position to 12,270 shares worth $96.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

Prudential Financial first reported a position in CRMD in Q1 2026 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Prudential Financial held 12,270 shares of CorMedix worth $96.3K as of Q2 2026.
  • Prudential Financial bought 880 CorMedix shares in Q2 2026, an estimated $6.95K.
  • CorMedix made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2344 holding.
  • Prudential Financial first reported a position in CorMedix in Q1 2026 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.